Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Allergy & Immunology
•
Immunosuppression
•
Anaphylaxis
•
Allergy
•
Immunology
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Patient with seropositive RA, immunodeficiency, and idiopathic anaphylaxis.
Related Questions
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How do you approach management of adult patients with CVID and sarcoid-like syndrome?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?